0001104659-20-076965.txt : 20200625
0001104659-20-076965.hdr.sgml : 20200625
20200625191617
ACCESSION NUMBER: 0001104659-20-076965
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200625
DATE AS OF CHANGE: 20200625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Partners Innovation Fund II, L.P.
CENTRAL INDEX KEY: 0001689717
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39343
FILM NUMBER: 20990553
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-307-2400
MAIL ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akouos, Inc.
CENTRAL INDEX KEY: 0001722271
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-245-5715
MAIL ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
3
1
a3.xml
3
X0206
3
2020-06-25
0
0001722271
Akouos, Inc.
AKUS
0001689717
Partners Innovation Fund II, L.P.
215 FIRST STREET, SUITE 500
CAMBRIDGE
MA
02142
0
0
1
0
Series Seed Preferred Stock
Common Stock
68501
D
Series A Preferred Stock
Common Stock
228336
D
Series B Preferred Stock
Common Stock
79998
D
The Series Seed Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC is the ultimate general partner of PIF II.
The Series A Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
The Series B Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
/s/ Partners Innovation Fund II, L.P. By: Julius Knowles, Authorized Signatory
2020-06-25